INTERNATIONAL PATENT: TSCAN THERAPEUTICS, INC. FILES APPLICATION FOR "MAGEC2 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEC2 IMMUNOGENIC PEPTIDES AND USES THEREOF"

GENEVA, Oct. 20 -- TSCAN THERAPEUTICS, INC. (830 Winter StreetWaltham, MA 02451) filed a patent application (PCT/US2025/023404) for "MAGEC2 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEC2 IMMUNOGENIC PEPTIDES, AND USES THEREOF" on Apr 07, 2025. With publication no. WO/2025/217028, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FERRETTI, Andrew, P. (c/o TScan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451), JUREWICZ, Mollie, M. (c/o TScan Therapeutics, Inc.830 Winter StreetWaltham, MA 02451), GURER, Cagan ...